Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional study.

Key Points

• The study aims to identify barriers affecting the use of biologics for psoriasis in Brazil.
• Conducted a cross-sectional analysis over 5 years of biologic access.
• Evaluated perceptions of healthcare providers and patients regarding biologic treatment.
• Focused on educational and structural barriers impacting treatment outcomes.
• Identified persistent barriers in education and communication regarding biologic use.
• Highlighted a need for better care pathways to enhance treatment accessibility.
• Demonstrated that improved physician-patient communication could lead to more equitable treatment outcomes.